Literature DB >> 16823041

Characterization of the native and fibrillar conformation of the human Nalpha-acetyltransferase ARD1.

Nuria Sánchez-Puig1, Alan R Fersht.   

Abstract

ARD1 (arrest-defective protein 1), together with NAT1 (N-acetyltransferase protein 1), is part of the major N(alpha)-acetyltransferase complex in eukaryotes responsible for alpha-acetylation of proteins and peptides. Protein acetylation has been implicated in gene expression regulation and protein-protein interaction. We characterized the native folded and misfolded conformation of hARD1. Structural characterization of native hARD1 using size exclusion chromatography, circular dichroism, and fluorescence spectroscopy shows the protein consists of a compact globular region comprising two thirds of the protein and a flexible unstructured C terminus. In addition, hARD1 forms protofilaments under physiological conditions of pH and temperature, as judged by electron microscopy and staining with the dyes Congo red and thioflavin T. The process is accelerated by thermal denaturation and high protein concentrations. Limited proteolysis of aggregated hARD1 revealed a resistant fragment whose sequence matched a region contained within the acetyl transferase domain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16823041      PMCID: PMC2242591          DOI: 10.1110/ps.062264006

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  43 in total

1.  Characterization of ARD1 variants in mammalian cells.

Authors:  Se-Hee Kim; Jeong Ae Park; Jin Hyoung Kim; Ji-Won Lee; Ji Hae Seo; Bo-Kyung Jung; Kwang-Hoon Chun; Joo-Won Jeong; Moon-Kyoung Bae; Kyu-Won Kim
Journal:  Biochem Biophys Res Commun       Date:  2005-12-15       Impact factor: 3.575

Review 2.  The structure of amyloid fibrils by electron microscopy and X-ray diffraction.

Authors:  M Sunde; C Blake
Journal:  Adv Protein Chem       Date:  1997

3.  Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis.

Authors:  D R Booth; M Sunde; V Bellotti; C V Robinson; W L Hutchinson; P E Fraser; P N Hawkins; C M Dobson; S E Radford; C C Blake; M B Pepys
Journal:  Nature       Date:  1997-02-27       Impact factor: 49.962

4.  Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1alpha and is not induced by hypoxia or HIF.

Authors:  Rebecca Bilton; Nathalie Mazure; Eric Trottier; Maurice Hattab; Marc-André Déry; Darren E Richard; Jacques Pouysségur; M Christiane Brahimi-Horn
Journal:  J Biol Chem       Date:  2005-07-01       Impact factor: 5.157

5.  Expression of N-acetyl transferase human and human Arrest defective 1 proteins in thyroid neoplasms.

Authors:  Thomas Arnesen; Darina Gromyko; Ole Horvli; Øystein Fluge; Johan Lillehaug; Jan Erik Varhaug
Journal:  Thyroid       Date:  2005-10       Impact factor: 6.568

6.  Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitro.

Authors:  Thomas A Murray-Rust; Neil J Oldham; Kirsty S Hewitson; Christopher J Schofield
Journal:  FEBS Lett       Date:  2006-02-17       Impact factor: 4.124

7.  Partially unfolded states of beta(2)-microglobulin and amyloid formation in vitro.

Authors:  V J McParland; N M Kad; A P Kalverda; A Brown; P Kirwin-Jones; M G Hunter; M Sunde; S E Radford
Journal:  Biochemistry       Date:  2000-08-01       Impact factor: 3.162

Review 8.  Over-production of proteins in Escherichia coli: mutant hosts that allow synthesis of some membrane proteins and globular proteins at high levels.

Authors:  B Miroux; J E Walker
Journal:  J Mol Biol       Date:  1996-07-19       Impact factor: 5.469

9.  The action of N-terminal acetyltransferases on yeast ribosomal proteins.

Authors:  R J Arnold; B Polevoda; J P Reilly; F Sherman
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

10.  The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

Authors:  Z Lai; W Colón; J W Kelly
Journal:  Biochemistry       Date:  1996-05-21       Impact factor: 3.162

View more
  11 in total

1.  Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups.

Authors:  Kenneth M Kaufman; Jian Zhao; Jennifer A Kelly; Travis Hughes; Adam Adler; Elena Sanchez; Joshua O Ojwang; Carl D Langefeld; Julie T Ziegler; Adrienne H Williams; Mary E Comeau; Miranda C Marion; Stuart B Glenn; Rita M Cantor; Jennifer M Grossman; Bevra H Hahn; Yeong Wook Song; Chack-Yung Yu; Judith A James; Joel M Guthridge; Elizabeth E Brown; Graciela S Alarcón; Robert P Kimberly; Jeffrey C Edberg; Rosalind Ramsey-Goldman; Michelle A Petri; John D Reveille; Luis M Vilá; Juan-Manuel Anaya; Susan A Boackle; Anne M Stevens; Barry I Freedman; Lindsey A Criswell; Bernardo A Pons Estel; Joo-Hyun Lee; Ji-Seon Lee; Deh-Ming Chang; R Hal A Scofield; Gary S Gilkeson; Joan T Merrill; Timothy B Niewold; Timothy James Vyse; Sang-Cheol Bae; Marta E Alarcón-Riquelme; Chaim O Jacob; Kathy Moser Sivils; Patrick M Gaffney; John B Harley; Amr H Sawalha; Betty P Tsao
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

2.  Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency.

Authors:  Alan F Rope; Kai Wang; Rune Evjenth; Jinchuan Xing; Jennifer J Johnston; Jeffrey J Swensen; W Evan Johnson; Barry Moore; Chad D Huff; Lynne M Bird; John C Carey; John M Opitz; Cathy A Stevens; Tao Jiang; Christa Schank; Heidi Deborah Fain; Reid Robison; Brian Dalley; Steven Chin; Sarah T South; Theodore J Pysher; Lynn B Jorde; Hakon Hakonarson; Johan R Lillehaug; Leslie G Biesecker; Mark Yandell; Thomas Arnesen; Gholson J Lyon
Journal:  Am J Hum Genet       Date:  2011-06-23       Impact factor: 11.025

3.  Arrest-defective-1 protein (ARD1): tumor suppressor or oncoprotein?

Authors:  Hsu-Ping Kuo; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2010-01-01       Impact factor: 4.060

Review 4.  The biological functions of Naa10 - From amino-terminal acetylation to human disease.

Authors:  Max J Dörfel; Gholson J Lyon
Journal:  Gene       Date:  2015-05-16       Impact factor: 3.688

5.  Expression, crystallization and preliminary X-ray crystallographic analyses of two N-terminal acetyltransferase-related proteins from Thermoplasma acidophilum.

Authors:  Sang Hee Han; Jun Yong Ha; Kyoung Hoon Kim; Sung Jin Oh; Do Jin Kim; Ji Yong Kang; Hye Jin Yoon; Se-Hee Kim; Ji Hae Seo; Kyu-Won Kim; Se Won Suh
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-10-20

6.  Composition and biological significance of the human Nalpha-terminal acetyltransferases.

Authors:  Kristian K Starheim; Darina Gromyko; Rolf Velde; Jan Erik Varhaug; Thomas Arnesen
Journal:  BMC Proc       Date:  2009-08-04

Review 7.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

8.  The protein Nalpha-terminal acetyltransferase hNaa10p (hArd1) is phosphorylated in HEK293 cells.

Authors:  Hiwa Målen; Johan R Lillehaug; Thomas Arnesen
Journal:  BMC Res Notes       Date:  2009-03-02

9.  De novo missense mutations in the NAA10 gene cause severe non-syndromic developmental delay in males and females.

Authors:  Bernt Popp; Svein I Støve; Sabine Endele; Line M Myklebust; Juliane Hoyer; Heinrich Sticht; Silvia Azzarello-Burri; Anita Rauch; Thomas Arnesen; André Reis
Journal:  Eur J Hum Genet       Date:  2014-08-06       Impact factor: 4.246

10.  Exome sequencing reveals NAA15 and PUF60 as candidate genes associated with intellectual disability.

Authors:  Jin J Zhao; Jonatan Halvardson; Cecilia S Zander; Ammar Zaghlool; Patrik Georgii-Hemming; Else Månsson; Göran Brandberg; Helena E Sävmarker; Carina Frykholm; Ekaterina Kuchinskaya; Ann-Charlotte Thuresson; Lars Feuk
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-10-09       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.